Viewing Study NCT06321068


Ignite Creation Date: 2025-12-24 @ 5:26 PM
Ignite Modification Date: 2025-12-28 @ 5:53 PM
Study NCT ID: NCT06321068
Status: TERMINATED
Last Update Posted: 2025-08-14
First Post: 2024-01-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: BAT1308 in Combination With Platinum-containing Chemotherapy is Used for the First-line Treatment of Advanced or Recurrent dMMR Endometrial Cancer
Sponsor: Bio-Thera Solutions
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: BAT-1308-003-CR
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators